Steven Neuhauser

8PUBLICATIONS

147CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 13, 2026

The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.

|Apr 06, 2026

PRECLINICAL ACTIVITY OF THE B7-H3- TARGETING ANTIBODY-DRUG CONJUGATE (ADC) VOBRAMITAMAB DUOCARMAZINE (VOBRA DUO) IN PEDIATRIC SOLID TUMORS.

Edward Favours, Haiying Tang, Peyton Wong

|Feb 13, 2026

Targeting Pediatric Glioblastomas by Combining OLIG2 Inhibitor CT-179 with Fractionated Radiation in a Panel of Patient-Derived Orthotopic Xenograft Mouse Models.

Holly Lindsay, Yuchen Du, Lin Qi

|Jan 10, 2026

Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma Models.

Yifei Wang, Zhongting Zhang, Caterina Longo

|Jan 02, 2026

Multicenter Histology Image Integration and Multiscale Deep Learning Support Machine Learning-Enabled Pediatric Sarcoma Classification.

Adam H Thiesen, Sergii Domanskyi, Ali Foroughi Pour

|Jun 30, 2025

Multicenter Histology Image Integration and Multiscale Deep Learning for Machine Learning-Enabled Pediatric Sarcoma Classification.

Adam Thiesen, Sergii Domanskyi, Ali Foroughi Pour

Pageof 2

Frequent Collaborators

Carol J Bult

Sergii Domanskyi

Jill C Rubinstein

Ali Foroughi Pour

Todd Sheridan

Timothy M Stearns

Jeffrey H Chuang

Emily L Jocoy

Xing Yi Woo

Brian J Sanderson

Frequent Collaborators

Carol J Bult

Sergii Domanskyi

Jill C Rubinstein

Ali Foroughi Pour